Company / Operating Income per Share
Caribou Biosciences, Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.61
FY2025
5-year range
-$3.53 / -$1.11
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 5 years, ranging from $-3.53 in FY2021 to $-1.11 in FY2022.
Based on SEC 10-K filings.
-1.61 in FY2025.
Improved from $-1.74 to $-1.61 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 22.4% year-over-year.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.61 | -22.4% |
| FY2024 | -$1.31 | +24.7% |
| FY2023 | -$1.74 | -56.9% |
| FY2022 | -$1.11 | +68.5% |
| FY2021 | -$3.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026